Screener
Vir Biotechnology, Inc. VIR Unrealized Gains on Investments
Unrealized Gains on Investments at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
| Line item | Valuation Hierarchy | June 30, 2026 / Amortized Cost | June 30, 2026 / Gross Unrealized Holding Gains | June 30, 2026 / Gross Unrealized Holding Losses | June 30, 2026 / Aggregate Fair Value |
|---|---|---|---|---|---|
| Asset-backed securities | Level 2 | 67,474 | 47 | (44) | 67,477 |
| Corporate bonds | Level 2 | 247,600 | 103 | (309) | 247,394 |
| Equity securities | Level 1 | N/A | N/A | N/A | 4,133 |
| Total financial assets | $952,734 | $192 | $(1,706) | $955,353 | |
| Reconciliation to cash, cash equivalents and investments on condensed consolidated balance sheet | |||||
| Minus: Restricted cash equivalents invested in money market funds | (7,923) | ||||
| Plus: Cash deposits | 60,312 | ||||
| Total cash, cash equivalents and investments | $1,007,742 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vir Biotechnology, Inc.'s unrealized gains on investments?
- Vir Biotechnology, Inc. (VIR) reported unrealized gains on investments of $192K in Q2 2026.
- How has Vir Biotechnology, Inc.'s unrealized gains on investments changed year-over-year?
- Vir Biotechnology, Inc.'s unrealized gains on investments decreased by 78.0% year-over-year, from $871K to $192K.
- What is the long-term trend for Vir Biotechnology, Inc.'s unrealized gains on investments?
- Over 2 years (2023 to 2025), Vir Biotechnology, Inc.'s unrealized gains on investments has grown at a 3.7% compound annual growth rate (CAGR), from $1.04M to $1.12M.
- What does unrealized gains on investments mean?
- The total unrealized gains on investments, typically related to available-for-sale securities.
Ask your AI about Vir Biotechnology, Inc.'s unrealized gains on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude